Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;141(3):481-483.
doi: 10.1016/j.jid.2020.08.004. Epub 2020 Sep 2.

Clinical Research after COVID-19: Embracing a New Normal

Joel M Gelfand  1 , Brooke E Hefele  2
Affiliations
Comment

Clinical Research after COVID-19: Embracing a New Normal

Joel M Gelfand et al. J Invest Dermatol. 2021 Mar.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is a grave public health crisis, causing massive disruption to daily life. Dermatology clinical trials in psoriasis, atopic dermatitis, and hidradenitis have been suspended, terminated, or otherwise disrupted. Clinical investigators need to embrace a COVID-19 new normal and adjust research procedures to mitigate the risk of transmitting severe acute respiratory syndrome coronavirus 2 and depleting personal protective equipment while maintaining scientific rigor.

PubMed Disclaimer

Comment on

  • The Impact of COVID-19 on Dermatology Clinical Trials.
    Desai S, Manjaly P, Lee KJ, Li SJ, Manjaly C, Mostaghimi A. Desai S, et al. J Invest Dermatol. 2021 Mar;141(3):676-678. doi: 10.1016/j.jid.2020.06.032. Epub 2020 Aug 14. J Invest Dermatol. 2021. PMID: 32805216 Free PMC article. No abstract available.

References

    1. Anderson M.L., Chiswell K., Peterson E.D., Tasneem A., Topping J., Califf R.M. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med. 2015;372:1031–1039. - PMC - PubMed
    1. Desai S., Manjaly P., Lee K.J., Li S.J., Manjaly C., Mostaghimi A. The impact of COVID-19 on dermatology clinical trials. J Invest Dermatol. 2021;141:676–678. - PMC - PubMed
    1. Gates B. Responding to COVID-19 - a once-in-a-century pandemic? N Engl J Med. 2020;382:1677–1679. - PubMed
    1. Gupta R., Ibraheim M.K., Doan H.Q. Teledermatology in the wake of COVID-19: advantages and challenges to continued care in a time of disarray. J Am Acad Dermatol. 2020;83:168–169. - PMC - PubMed
    1. Hefele B., Langan S.M., Pollins K., Gelfand J.M. Engaging the patient’s perspective in clinical trials research. J Invest Dermatol. 2019;139:1217–1220. - PMC - PubMed